Bill would free up $1B in FDA fees; Shionogi wants women to talk about dyspareunia; Sun Pharma recalls some Nimodine;

@FiercePharma: Peace treaty in Vivus proxy war: $VVUS hands board control to rebels, with new CEO Zook poised to step in. Report | Follow @FiercePharma

 @EricPFierce: From FierceVaccines.com: ABC's appointment of Jenny McCarthy sparks media furor. Story | Follow @EricPFierce

 @CarlyHFierce: Vivus, First Manhattan reach agreement - Wilson out as CEO and 6 FMC candidates join board. Article | Follow @CarlyHFierce

> A bipartisan bill in Congress would free up about $1 billion in user fees that the FDA could use to do its work. Story | More from FierceMedicalDevices

> Perrigo ($PRGO) said today that the FDA has given it tentative approval to make a generic version of Novo Nordisk's ($NVO) Type 2 diabetes pill Prandin. Release

> India's Sun Pharma has recalled lots of brain haemorrhage drug Nimodine in the U.S. due to "crystallisation.'' Report

> Astellas Pharma has launched its advanced prostate cancer drug Xtandi  in the U.K. Report

Medical Device News

@FierceMedDev: Stryker's sales up 5%, but recalls swallow profits. Report | Follow @FierceMedDev

 @MarkHFierce: ArthroCare's ex-CEO and former CFO both face multiple charges in a $400M fraud scheme. ICYMI yesterday | Follow @MarkHFierce

@DamianFierce: A House group has introduced the FDA SOS Act, designed to save user fees from sequester cuts. Report | Follow @DamianFierce

> LabCorp lowers outlook as profits slide. Article

> Intuitive's surgical robot juggernaut shows some cracks in Q2. More

> Hologic CEO resigns, citing personal reasons. Item

Biotech News

@FierceBiotech: $1.3B VC cash surge buoys biotech as analysts point to a rebound. More | Special Report: The Top 15 Biotech VC firms | Follow @FierceBiotech

 @JohnCFierce: Novartis buries a PhIII kidney cancer failure behind Q2 successes. News | Follow @JohnCFierce

@RyanMFierce: After Nobel Prize, Japan wants to take lead in iPSC therapy with approval of clinical trial. Article | Follow @RyanMFierce

 @EmilyMFierce: The latest at FierceBiotechResearch.com: Revalesio drug alters Alzheimer's progression in animal model. Story | Follow @EmilyMFierce

> Japan green-lights trial for adult stem cell therapy for eye disease. More

> U.K. pharma group's cannabis-based diabetes drug sparks insulin output. More

> Report: Pfizer backs off Onyx bid as price gets too rich. Article

And Finally... Shionogi launched a consumer website to promote its post-menopausal treatment Osphena. The site features actress Virginia Madsen and is designed as a forum for women to discuss the painful sex condition dyspareunia. Report

Suggested Articles

The company will commit $300 million over the next five years to hire more people of color and increase clinical trial diversity.

Moderna, after tapping almost $1 billion in federal funding, agreed to deliver 100 million doses of its vaccine candidate for up to $1.5 billion.

FDA advisors will question the clinical data and manufacturing for Mesoblast's Ryoncil, a cell therapy for pediatric acute graft vs. host disease.